Loading...
Market
Will Rapport Therapeutics' market cap exceed $1 billion by September 30, 2024?
5
Resolution / Starting Odds
Yes • 50%
No • 50%
Market cap data from NASDAQ or financial data providers
Story
Rapport Therapeutics Prices IPO at $17 Per Share for 8 Million Shares, Raises $136 Million
Jun 7, 2024, 12:25 AM
Rapport Therapeutics Inc. (RAPP) has successfully priced its initial public offering (IPO), setting the stage for its debut on Friday. The company priced a full size deal of 8 million shares at $17 each, which is the midpoint of the expected range. The IPO has raised $136 million, and the offering is backed by prominent investors including Johnson & Johnson (JNJ). The pricing of the IPO marks a significant milestone for Rapport Therapeutics as it prepares to enter the public market.
View original story
Similar markets
Below $100M • 33%
$100M-$200M • 33%
Above $200M • 33%
Below $5 billion • 25%
$5 billion to $10 billion • 25%
$10 billion to $15 billion • 25%
Above $15 billion • 25%
Below $1 billion • 33%
$1 billion to $2 billion • 33%
Above $2 billion • 34%